Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Challenges for accurate susceptibility testing, detection and interpretation of β-lactam resistance phenotypes in Pseudomonas aeruginosa: results from a Spanish multicentre study.

Juan C, Conejo MC, Tormo N, Gimeno C, Pascual Á, Oliver A.

J Antimicrob Chemother. 2013 Mar;68(3):619-30. doi: 10.1093/jac/dks439. Epub 2012 Nov 9.

PMID:
23143898
2.

Quality control for beta-lactam susceptibility testing with a well-defined collection of Enterobacteriaceae and Pseudomonas aeruginosa strains in Spain.

Cantón R, Loza E, Del Carmen Conejo M, Baquero F, Martínez-Martínez L; MENSURA Collaborative Group.

J Clin Microbiol. 2003 May;41(5):1912-8.

3.

Challenges to accurate susceptibility testing and interpretation of quinolone resistance in Enterobacteriaceae: results of a Spanish multicentre study.

Rodriguez-Martinez JM, Machuca J, Calvo J, Diaz-de-Alba P, Rodríguez-Mirones C, Gimeno C, Martinez-Martinez L, Pascual Á.

J Antimicrob Chemother. 2015 Jul;70(7):2038-47. doi: 10.1093/jac/dkv059. Epub 2015 Mar 4.

PMID:
25745103
4.

Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.

Llanes C, Pourcel C, Richardot C, Plésiat P, Fichant G, Cavallo JD, Mérens A; GERPA Study Group.

J Antimicrob Chemother. 2013 Aug;68(8):1763-71. doi: 10.1093/jac/dkt115. Epub 2013 Apr 29.

PMID:
23629014
5.

Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital study.

Cavallo JD, Hocquet D, Plesiat P, Fabre R, Roussel-Delvallez M; GERPA (Groupe d'Etude de la Résistance de Pseudomonas aeruginosa aux antibiotiques).

J Antimicrob Chemother. 2007 May;59(5):1021-4. Epub 2007 Apr 5.

PMID:
17412726
7.

Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.

Fournier D, Richardot C, Müller E, Robert-Nicoud M, Llanes C, Plésiat P, Jeannot K.

J Antimicrob Chemother. 2013 Aug;68(8):1772-80. doi: 10.1093/jac/dkt098. Epub 2013 Apr 14.

PMID:
23587654
8.
9.

Detection of P. aeruginosa harboring bla CTX-M-2, bla GES-1 and bla GES-5, bla IMP-1 and bla SPM-1 causing infections in Brazilian tertiary-care hospital.

Polotto M, Casella T, de Lucca Oliveira MG, Rúbio FG, Nogueira ML, de Almeida MT, Nogueira MC.

BMC Infect Dis. 2012 Aug 3;12:176. doi: 10.1186/1471-2334-12-176.

10.

Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: a multicenter external proficiency study using a well-defined collection of Escherichia coli strains.

Ripoll A, Galán JC, Rodríguez C, Tormo N, Gimeno C, Baquero F, Martínez-Martínez L, Cantón R; SEIMC Quality Control Study Group.

J Clin Microbiol. 2014 Jan;52(1):122-9. doi: 10.1128/JCM.02340-13. Epub 2013 Oct 23.

11.

Performance of Vitek 2 in antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates with different mechanisms of beta-lactam resistance.

Mazzariol A, Aldegheri M, Ligozzi M, Lo Cascio G, Koncan R, Fontana R.

J Clin Microbiol. 2008 Jun;46(6):2095-8. doi: 10.1128/JCM.02216-07. Epub 2008 Apr 23.

12.

Distribution of Ambler class A, B and D β-lactamases among Pseudomonas aeruginosa isolates.

Tawfik AF, Shibl AM, Aljohi MA, Altammami MA, Al-Agamy MH.

Burns. 2012 Sep;38(6):855-60. doi: 10.1016/j.burns.2012.01.005. Epub 2012 Feb 19.

PMID:
22348803
13.

Phenotypic detection and polymerase chain reaction screening of extended-spectrum β-lactamases produced by Pseudomonas aeruginosa isolates.

Lin SP, Liu MF, Lin CF, Shi ZY.

J Microbiol Immunol Infect. 2012 Jun;45(3):200-7. doi: 10.1016/j.jmii.2011.11.015. Epub 2011 Dec 29.

14.

[Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].

Susić E.

Acta Med Croatica. 2004;58(4):307-12. Croatian.

PMID:
15700687
15.
16.

Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).

Dubois V, Arpin C, Dupart V, Scavelli A, Coulange L, André C, Fischer I, Grobost F, Brochet JP, Lagrange I, Dutilh B, Jullin J, Noury P, Larribet G, Quentin C.

J Antimicrob Chemother. 2008 Aug;62(2):316-23. doi: 10.1093/jac/dkn174. Epub 2008 May 8.

PMID:
18467306
17.

Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.

Rizvi M, Fatima N, Rashid M, Shukla I, Malik A, Usman A, Siddiqui S.

J Infect Dev Ctries. 2009 May 1;3(4):285-94.

18.

Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.

Rizvi M, Fatima N, Rashid M, Shukla I, Malik A, Usman A, Siddiqui S.

J Infect Dev Ctries. 2009 Apr 30;3(3):177-86.

19.

[Study on the drug resistance and beta-lactamases of Pseudomonas aeruginosa].

Wang J, Zhou JY, Yu YS.

Zhonghua Jie He He Hu Xi Za Zhi. 2005 Apr;28(4):258-62. Chinese.

PMID:
15854438
20.

Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.

Riera E, Cabot G, Mulet X, García-Castillo M, del Campo R, Juan C, Cantón R, Oliver A.

J Antimicrob Chemother. 2011 Sep;66(9):2022-7. doi: 10.1093/jac/dkr232. Epub 2011 Jun 8.

PMID:
21653605

Supplemental Content

Support Center